Platinum

NORNICKEL'S GLOBAL PALLADIUM FUND LAUNCHES WORLD'S FIRST PHYSICALLY-BACKED ELECTRIC VEHICLE METALS ETC

Retrieved on: 
Tuesday, February 1, 2022

Moscow, February 1, 2022 - Nornickel, the world's largest producer of palladium and high-grade nickel and a major producer of platinum and copper, announces that Global Palladium Fund, a metals distributor founded by Nornickel, has launched the GPF Physical Electric Vehicle Metals Exchange Traded Commodity (ETC).

Key Points: 
  • Moscow, February 1, 2022 - Nornickel, the world's largest producer of palladium and high-grade nickel and a major producer of platinum and copper, announces that Global Palladium Fund, a metals distributor founded by Nornickel, has launched the GPF Physical Electric Vehicle Metals Exchange Traded Commodity (ETC).
  • The Global Palladium Fund Physical Electric Vehicle ETC is being launched with $10m of seed capital, and listing initially on Borsa Italiana.
  • The ETC is backed by physical metal and will track the performance of the Solactive GPF Electric Vehicle Index.
  • The bespoke index is made up of metals based on their use across four electric vehicle segments: battery (BEV), hybrid (HEV), plug-in hybrid (PHEV) and fuel cell (FCEV).

Future Digital Award Winners Announced for Telco Innovation 2022

Retrieved on: 
Tuesday, February 1, 2022

Congratulations to Juniper Research for yet another successful edition of the Future Digital Awards.

Key Points: 
  • Congratulations to Juniper Research for yet another successful edition of the Future Digital Awards.
  • "I am very proud that Kaleyra is the Gold Winner of the Juniper Research Future Digital Awards 2022 for CPaaS Provider of the Year.
  • It is why Neustar is so honoured to receive Juniper Research's 2022 Platinum Award for Best Robocall Mitigation Solution for Telco Innovation, said James Garvert, Neustar senior vice president and general manager, Communications Solutions.
  • For further details on the Future Digital Awards please visit the Future Digital Awards website , follow us on Twitter @FutureDigiAward , or contact [email protected].

SSR MINING ACHIEVES TOP END OF 2021 PRODUCTION GUIDANCE, BEATS AISC GUIDANCE, OUTLINES THREE-YEAR OUTLOOK AND INTENDS TO INCREASE 2022 DIVIDEND BY 40%

Retrieved on: 
Monday, January 31, 2022

Accordingly, AISC in the second and third quarters of 2022 are expected to be above the full-year 2022 guidance range.

Key Points: 
  • Accordingly, AISC in the second and third quarters of 2022 are expected to be above the full-year 2022 guidance range.
  • Gold production was 57,405 ounces in the fourth quarter of 2021, a strong finish to the year despite a build-up of gold in inventory.
  • In 2022, Marigold production is expected to be 215,000 to 245,000 ounces of gold at mine site AISC of $1,245 to $1,295 per ounce.
  • AISC includes total production costs incurred at the Company's mining operations, which forms the basis of its by-product cash costs.

Call for Entries: NAREE's 72nd Annual Real Estate Journalism Competition Module Opens Feb. 1

Retrieved on: 
Monday, January 31, 2022

The National Association of Real Estate Editors has issued a call for entries for NAREE's 72nd Annual Journalism Competition.

Key Points: 
  • The National Association of Real Estate Editors has issued a call for entries for NAREE's 72nd Annual Journalism Competition.
  • NAREEs journalism competition is open to reporters, columnists, writers, editors, and freelancers covering commercial and residential real estate, mortgage finance, sustainable development, and related real estate fields, including home building and design.
  • Competition categories for work with a single byline include Best Collection of Work - Residential Real Estate, Best Collection of Work - Commercial Real Estate, Best Column, Best Economic Analysis, Best Architecture story, Best Interior Design story, and the Kenneth R. Harney Award for Best Consumer Education Reporting.
  • Categories for individual writers published in a daily or weekly newspaper include Best Residential Real Estate Story, and Best Commercial Real Estate Story.

Aptar Receives Platinum Rating from EcoVadis

Retrieved on: 
Monday, January 31, 2022

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has received the Platinum level rating in recognition of its sustainability efforts from EcoVadis.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has received the Platinum level rating in recognition of its sustainability efforts from EcoVadis.
  • The Platinum rating places Aptar among the top 1% of the nearly 85,000 companies rated by EcoVadis across all industries.
  • View the full release here: https://www.businesswire.com/news/home/20220131005122/en/
    We are extremely pleased that we have achieved Platinum status from EcoVadis.
  • EcoVadis Platinum status is certainly a major accomplishment for Aptar as we have progressed year by year.

PennEnergy Resources Achieves Project Canary Certification Across Entire Operating Asset

Retrieved on: 
Monday, January 31, 2022

PITTSBURGH and DENVER , Jan. 31, 2022 /PRNewswire/ --PennEnergy Resources, LLC, a privately-held exploration and production company, achieved Project Canary's TrustWell certification across its entire operating asset and earned the highest ratings on 99% of its wells, the companies announced today.

Key Points: 
  • PITTSBURGH and DENVER , Jan. 31, 2022 /PRNewswire/ --PennEnergy Resources, LLC, a privately-held exploration and production company, achieved Project Canary's TrustWell certification across its entire operating asset and earned the highest ratings on 99% of its wells, the companies announced today.
  • Project Canary initiated its TrustWell environmental certification process in Q3-2021, in which PennEnergy Resources' operations, across 378 wells were measured against strict environmental and social standards regarding, air, water, land and community.
  • Project Canary delivers trusted and reliable independent energy ESG data through TrustWell certification and continuous monitoring technology.
  • Project Canary's differentiated TrustWell certification process independently analyzes 600+ data points across the ESG spectrum on a well-by-well basis to create a dynamic score.

DARK & LOVELY BRINGS BRIGHT, BOLD & BLONDE HOME WITH NEW UPLIFT BLEACH KIT

Retrieved on: 
Monday, January 31, 2022

"As a newly converted blonde, I am thrilled for the launch of Dark & Lovely's new Bleach Kit," said actress, producer and Dark & Lovely Brand Ambassador,Storm Reid.

Key Points: 
  • "As a newly converted blonde, I am thrilled for the launch of Dark & Lovely's new Bleach Kit," said actress, producer and Dark & Lovely Brand Ambassador,Storm Reid.
  • "The Dark & Lovely Uplift Bleach Kit does just that, making it the perfect at-home staple for blonde bombshells."
  • The Dark & Lovely Uplift Bleach Kit is available for $8.49 at Walmart stores nationwide and Walmart.com.
  • For more information about Dark & Lovely and the Uplift Bleach Kit, please visit DarkAndLovely.com or follow us on Instagram , Facebook , Twitter and YouTube .

Aravive Announces First Patient Dosed in Phase 2 Study of Batiraxcept in Clear Cell Renal Cell Carcinoma

Retrieved on: 
Monday, January 31, 2022

HOUSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that the Company has dosed the first patient in the Phase 2 portion of the Phase 1b/2 study of batiraxcept for the treatment of clear cell renal cell carcinoma (ccRCC).

Key Points: 
  • HOUSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that the Company has dosed the first patient in the Phase 2 portion of the Phase 1b/2 study of batiraxcept for the treatment of clear cell renal cell carcinoma (ccRCC).
  • The Phase 2 portion of the Phase 1b/2 clinical trial of batiraxcept in ccRCC is an open-label study in which 55 patients are anticipated to enroll across three parts.
  • Part A is expected to enroll approximately 25 patients and will investigate batiraxcept 15 mg/kg in combination with cabozantinib in 2L+ ccRCC patients.
  • Batiraxcept is in an active registrational Phase 3 trial in platinum resistant ovarian cancer (NCT04729608), a Phase 1b/2 trial in clear cell renal cell carcinoma (NCT04300140), and a Phase 1b/2 trial in pancreatic adenocarcinoma (NCT04983407).

Magna Mining Inc's Shakespeare Nickel Project Feasibility Study Demonstrates Positive Economics and Carbon Neutral Nickel Mining Operation

Retrieved on: 
Monday, January 31, 2022

Mineral reserves are stated within the final pit design based on metal prices of US$ 6.50/lb.

Key Points: 
  • Mineral reserves are stated within the final pit design based on metal prices of US$ 6.50/lb.
  • Underground resources have been outlined beneath the Feasibility open pit which may represent an opportunity for low-cost, bulk underground mining.
  • Reserves for the Study were calculated using US$6.50/lb nickel, US$3.00/lb copper, US$17/lb cobalt, US$900/oz platinum, US$1700/oz palladium and US$1500/oz gold.
  • Magna Mining is an exploration and development company focused on nickel, copper and PGM projects in the Sudbury Region of Ontario, Canada.

Fennec Pharmaceuticals Announces Management Change

Retrieved on: 
Monday, January 31, 2022

On behalf of the Board of Directors and leadership team, we thank Shubh for her many contributions to the Company.

Key Points: 
  • On behalf of the Board of Directors and leadership team, we thank Shubh for her many contributions to the Company.
  • We continue to prepare for a commercial launch upon approval, said Rosty Raykov, chief executive officer ofFennec Pharmaceuticals, Inc. Fennec remains committed to making PEDMARKavailable to children and young adults receiving cisplatin chemotherapy, who currently have no approved therapies for ototoxicity.
  • Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development of PEDMARKfor the prevention of platinum-induced ototoxicity in pediatric patients.
  • Fennec disclaims any obligation to update these forward-looking statements except as required by law.